No Data
No Data
US FDA Accepts for Priority Review Sanofi's Bullous Pemphigoid Treatment
FDA Approves Sanofi Biosimilar Product for Treatment of Diabetes
Sanofi Price Target Raised to EUR 110 From EUR 105 at JPMorgan
Express News | U.S. FDA Approves Sanofi-Aventis U.S' Merilog & Merilog Solostar, Biosimilars To Novo Nordisk's Novolog
How Is The Market Feeling About Sanofi?
'Make America Healthy Again' Platform to Be a Top Priority of RFK Jr. at HHS